RecruitingNCT06523543

Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells

Sponsor

University Hospital, Montpellier

Enrollment

25 participants

Start Date

Nov 19, 2024

Study Type

OBSERVATIONAL

Conditions

Pregnant women

Summary

Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Inclusion (Visit 1 - Week 7-16), Second semester of pregnancy (Visit 2 - Week 20-24), and others for people with pregnant women. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREInclusion (Visit 1 - Week 7-16)

Extraction of cervico-vaginal sampling

DIAGNOSTIC_TESTSecond semester of pregnancy (Visit 2 - Week 20-24)

Ultrasound examination (determination of chromosomal sex)

DIAGNOSTIC_TESTThird semester of pregnancy (Visit 3- Week 34)

Ultrasound examination (determination of chromosomal sex) if this has not be done during the Visit 2 or if a new determination correcting the previous one is provided.